U.S. flag

An official website of the United States government

NM_174878.3(CLRN1):c.368C>A (p.Ala123Asp) AND Usher syndrome type 3

Germline classification:
Likely pathogenic (3 submissions)
Last evaluated:
Jun 27, 2014
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000041436.9

Allele description [Variation Report for NM_174878.3(CLRN1):c.368C>A (p.Ala123Asp)]

NM_174878.3(CLRN1):c.368C>A (p.Ala123Asp)

Gene:
CLRN1:clarin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q25.1
Genomic location:
Preferred name:
NM_174878.3(CLRN1):c.368C>A (p.Ala123Asp)
HGVS:
  • NC_000003.12:g.150941647G>T
  • NG_009168.1:g.36353C>A
  • NM_001195794.1:c.368C>A
  • NM_001256819.2:c.540C>A
  • NM_052995.2:c.140C>A
  • NM_174878.3:c.368C>AMANE SELECT
  • NP_001182723.1:p.Ala123Asp
  • NP_001243748.1:p.Cys180Ter
  • NP_443721.1:p.Ala47Asp
  • NP_777367.1:p.Ala123Asp
  • LRG_700t1:c.368C>A
  • LRG_700t2:c.140C>A
  • LRG_700:g.36353C>A
  • LRG_700p1:p.Ala123Asp
  • LRG_700p2:p.Ala47Asp
  • NC_000003.11:g.150659434G>T
  • NM_174878.2:c.368C>A
  • NR_046380.3:n.538C>A
  • c.368C>A
Protein change:
A123D
Links:
dbSNP: rs374963432
NCBI 1000 Genomes Browser:
rs374963432
Molecular consequence:
  • NM_001195794.1:c.368C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_052995.2:c.140C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_174878.3:c.368C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_046380.3:n.538C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001256819.2:c.540C>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Usher syndrome type 3
Synonyms:
Usher Syndrome, Type III
Identifiers:
MONDO: MONDO:0016485; MedGen: C1568248

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000220455Counsyl
criteria provided, single submitter

(Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015))
Likely pathogenic
(Jun 27, 2014)
unknownliterature only

PubMed (3)
[See all records that cite these PMIDs]

Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015),

Citation Link,

SCV001162963Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002081534Natera, Inc.
no assertion criteria provided
Pathogenic
(Jan 13, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Two novel disease-causing mutations in the CLRN1 gene in patients with Usher syndrome type 3.

García-García G, Aparisi MJ, Rodrigo R, Sequedo MD, Espinós C, Rosell J, Olea JL, Mendívil MP, Ramos-Arroyo MA, Ayuso C, Jaijo T, Aller E, Millán JM.

Mol Vis. 2012;18:3070-8. Epub 2012 Dec 29.

PubMed [citation]
PMID:
23304067
PMCID:
PMC3538041

Disease-causing mutations in the CLRN1 gene alter normal CLRN1 protein trafficking to the plasma membrane.

Isosomppi J, Västinsalo H, Geller SF, Heon E, Flannery JG, Sankila EM.

Mol Vis. 2009 Sep 8;15:1806-18.

PubMed [citation]
PMID:
19753315
PMCID:
PMC2742642
See all PubMed Citations (4)

Details of each submission

From Counsyl, SCV000220455.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV001162963.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002081534.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024